CRIS Current Research Information System

CHIARINI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.675
EU - Europa 1.480
AS - Asia 471
AF - Africa 107
SA - Sud America 5
OC - Oceania 3
Totale 3.741
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.668
GB - Regno Unito 362
IT - Italia 357
SE - Svezia 233
DE - Germania 187
CN - Cina 153
VN - Vietnam 144
SG - Singapore 80
IN - India 69
UA - Ucraina 63
IE - Irlanda 62
TG - Togo 43
RU - Federazione Russa 42
FR - Francia 40
EE - Estonia 35
ZA - Sudafrica 26
CH - Svizzera 24
CI - Costa d'Avorio 24
BG - Bulgaria 19
JO - Giordania 17
BE - Belgio 14
FI - Finlandia 12
HR - Croazia 9
NG - Nigeria 9
NL - Olanda 7
CA - Canada 6
SC - Seychelles 5
GR - Grecia 4
CZ - Repubblica Ceca 3
BR - Brasile 2
DK - Danimarca 2
NZ - Nuova Zelanda 2
AL - Albania 1
AR - Argentina 1
AT - Austria 1
AU - Australia 1
BD - Bangladesh 1
BS - Bahamas 1
CL - Cile 1
EC - Ecuador 1
JP - Giappone 1
KG - Kirghizistan 1
LB - Libano 1
MD - Moldavia 1
MY - Malesia 1
PT - Portogallo 1
SA - Arabia Saudita 1
SI - Slovenia 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 3.741
Salva come PNG Salva come JPEG
Città #
Southend 316
Fairfield 204
Chandler 193
Ashburn 167
Parma 128
Dong Ket 111
Ann Arbor 97
Wilmington 97
Woodbridge 96
Houston 92
Seattle 87
Princeton 80
Cambridge 73
Singapore 69
Bologna 64
Dublin 62
Lomé 43
Nanjing 31
Westminster 31
Jacksonville 30
Padova 30
Abidjan 24
Bremen 23
Berlin 21
Reggio Emilia 19
Sofia 19
Bern 18
Saint Petersburg 18
Amman 17
Turin 17
Jinan 15
Shenyang 15
Beijing 13
Brussels 13
Boardman 12
Des Moines 12
Florence 12
Nanchang 12
Santa Clara 12
Helsinki 11
San Diego 11
Abeokuta 9
Changsha 9
Medford 9
Washington 9
Hebei 8
New York 8
Los Angeles 7
Redmond 7
Tianjin 7
Falls Church 6
Mülheim 6
Ningbo 6
Olalla 6
Redwood City 6
Haikou 5
Mahé 5
Mountain View 5
Norwalk 5
Toronto 5
Durham 4
Jiaxing 4
London 4
Milan 4
Phoenix 4
Rome 4
San Francisco 4
Shanghai 4
Tappahannock 4
Verona 4
Bühl 3
Hangzhou 3
Lausanne 3
Urbino 3
Cedar Knolls 2
Dearborn 2
Den Haag 2
Ferrara di Monte Baldo 2
Fuzhou 2
Groningen 2
Guangzhou 2
Kuban 2
Kunming 2
Moscow 2
Oxford 2
Putignano 2
Rimini 2
San Felice sul Panaro 2
San Ferdinando Di Puglia 2
São Paulo 2
Taiyuan 2
Taizhou 2
Tallinn 2
Ulan-ude 2
Zhengzhou 2
Andover 1
Athens 1
Auckland 1
Augusta 1
Bangalore 1
Totale 2.642
Salva come PNG Salva come JPEG
Nome #
Antigene MYCN Silencing by BGA002 Inhibits SCLC Progression Blocking mTOR Pathway and Overcomes Multidrug Resistance 216
Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235, against T-cell acute lymphoblastic leukemia. 169
AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications. 137
Toxicity of antimony trioxide nanoparticles on human hematopoietic progenitor cells and comparison to cell lines. 132
Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapy 120
PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors. 119
Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms. 115
Involvement of nuclear PLC{beta}1 in lamin B1 phosphorylation and G2/M cell cycle progression. 114
The Emerging Role of the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Network in Cancer Stem Cell Biology. 112
A role of PI-PLCb1 in G1/S transition in human erythroleukemia k562 cells 110
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS 110
The cyclin-dependent kinase inhibitor roscovitine and the nucleoside analog sangivamycin induce apoptosis in caspase-3 deficient breast cancer cells independent of caspase mediated P-glycoprotein cleavage 109
Effect of Lenalidomide Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients 108
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-ami ne (A443654) in T-cell acute lymphoblastic leukemia. 106
The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation 104
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells 100
The phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin signaling network and the control of normal myelopoiesis 98
The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resisten human T-acute leukemia cells by a JNK-dependent mechanism 98
Lamin A and prelamin A counteract invasiveness of osteosarcoma cells 97
Synergistic induction of PI-PLCbeta1 signaling by azacitidine and valproic acid in high-risk myelodysplastic syndromes 96
Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS. 96
Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia. 95
Effect of Erythropoietin Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients. 95
Synergistic proapoptotic activity of recombinant TRAIL plus the Akt inhibitor perifosine in acute myeloid leukemia cells. 92
Dual inhibition of class IA phoshatidylinositol 3-kinase and mTOR as a new therapeutic option for T-cell acute lymphoblastic leukemia. 84
Inhibition of methyltransferase dot1l sensitizes to sorafenib treatment aml cells irrespective of mll-rearrangements: A novel therapeutic strategy for pediatric aml 80
Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedside. 77
The emerging role of the phosphatidylinositol 3-kinase/Akt/mTOR signaling network in normal myelopoieis and leukemogenesis. 76
null 75
Lamin A acts a tumor suppressor in Ewing sarcoma promoting neural differentiation and reducing cell migration and invasion 75
Assessment of the structural and functional characteristics of human mesenchymal stem cells associated with a prolonged exposure of morphine 75
Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107). 73
null 69
Temsirolimus, An Allosteric mTORC1 Inhibitor, Is Synergistic with Clofarabine in AML and AML Leukemia Initiating Cells 64
A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES 58
The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients 56
Cellular senescence in vascular wall mesenchymal stromal cells, a possible contribution to the development of aortic aneurysm 55
The role played by Wnt/beta-catenin signaling pathway in acute lymphoblastic leukemia. 47
Targeting metabolic vulnerabilities and aberrant signal transduction pathways in paediatric T-cell Acute Lymphoblastic Leukaemia (T-ALL) 45
The unfolded protein response: a novel therapeutic target in acute leukemias. 35
Targeting the phosphatidylinositol 3-kinase/Akt/mTOR signaling network in acute myelogenous leukaemia. 28
Preclinical testing of the Akt inhibitor triciribine in T-cell acute lymphoblastic leukemia 28
Totale 3.848
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.405
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.405
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020692 0 0 6 54 78 77 102 92 127 62 33 61
2020/2021455 84 33 26 11 17 12 6 33 39 22 21 151
2021/2022797 87 24 54 54 68 32 15 64 25 128 140 106
2022/2023928 81 117 47 121 68 76 34 48 157 35 91 53
2023/2024358 19 41 33 42 24 62 13 13 10 38 21 42
2024/2025144 31 113 0 0 0 0 0 0 0 0 0 0
Totale 3.848